Targeted deep sequencing of urothelial bladder cancers and associated urinary <scp>DNA</scp> : a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification

Abstract

SMs are reliably detected in urinary cpDNA and cfDNA. The technical capability to identify very low MAFs is essential to reliably detect UBC, regardless of the use of cpDNA or cfDNA. This 23-gene panel shows promise for the non-invasive diagnosis and risk stratification of UBC.